Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

C1orf149 Activators

Akt Activators are a diverse array of chemical compounds that indirectly promote the functional activity of the protein Akt through modulation of various cellular signaling pathways. Forskolin, by elevating cAMP levels, indirectly stimulates Akt through PKA activation, which can phosphorylate regulatory proteins that might affect Akt signaling positively. Ionomycin increases intracellular calcium, which could trigger the activation of calcium-dependent protein kinases, facilitating the activation of Akt or related pathways. The PI3K inhibitor LY294002 might enhance Akt activity by disrupting negative feedback loops, while U0126, a MEK inhibitor, could favor Akt activation by reducing competitive MAPK/ERK signaling. Sunitinib's inhibition of tyrosine kinases may allow for enhanced Akt activity by mitigating negative regulatory effects from these pathways. Additionally, the modulation of cellular redox states by N-acetylcysteine could create conditions favoring Akt activation.

Other chemicals contribute to the indirect activation of Akt through metabolic modifications and alterations in gene expression. AICAR, an AMPK activator, induces metabolic shifts that can impact Akt, with AMPK's influence on mTOR signaling potentially facilitating Akt activation. Rosiglitazone, as a PPARγ agonist, may enhance Akt activity by modulating related gene expression networks. Epigallocatechin gallate's kinase-inhibiting properties may reduce competitive signaling, leading to an indirect increase in Akt activation. PMA's activation of PKC, along with SB203580's inhibition of p38 MAPK, can alter signaling pathways intersecting with Akt, which may enhance its activation. Furthermore, TrichostatinA, as a histone deacetylase inhibitor, may influence the expression of proteins that regulate Akt, thus potentially impacting Akt's activation indirectly. Collectively, these chemical activators, through their targeted effects on various signaling pathways and cellular processes, support the enhancement of Akt-mediated functions, demonstrating the complex interplay of intracellular signaling and its influence on Akt activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calmodulin-dependent kinase (CaMK), which may indirectly lead to the activation of Akt through phosphorylation events.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor that can alter the downstream AKT signaling pathway. By inhibiting PI3K, LY294002 may reduce negative feedback loops, potentially allowing for an increase in Akt activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

U0126 is a MEK inhibitor that can shift the balance of signaling through the MAPK/ERK pathway. By inhibiting MEK, U0126 may indirectly enhance Akt activation by reducing crosstalk that inhibits Akt.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$153.00
$938.00
5
(0)

Sunitinib is a tyrosine kinase inhibitor that might indirectly increase Akt activity by reducing competition from other tyrosine kinase signaling pathways that can negatively regulate Akt.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

N-acetylcysteine modulates cellular redox states, which can affect signaling pathways intersecting with Akt's regulation, potentially leading to enhanced Akt activation.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$65.00
$280.00
$400.00
48
(2)

AICAR activates AMP-activated protein kinase (AMPK), which can lead to metabolic changes influencing Akt activity. AMPK activation can also alter mTOR signaling, a pathway closely linked to Akt activation.

Rosiglitazone

122320-73-4sc-202795
sc-202795A
sc-202795C
sc-202795D
sc-202795B
25 mg
100 mg
500 mg
1 g
5 g
$120.00
$326.00
$634.00
$947.00
$1259.00
38
(1)

Rosiglitazone is a PPARγ agonist that can alter gene expression patterns, influencing signaling pathways that may intersect with Akt's regulatory network, possibly leading to enhanced Akt activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

Epigallocatechin gallate inhibits multiple kinases, which could result in reduced competitive signaling and indirectly enhance Akt activation by altering the cellular signaling landscape.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA is an activator of protein kinase C (PKC), which can modulate the signaling pathways that intersect with Akt, potentially enhancing its activation.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is an inhibitor of p38 MAPK, which can shift signaling dynamics to favor pathways that activate Akt, indirectly leading to enhanced Akt activity.